Cell Transplantation Combined with Recombinant Collagen Peptides for the Treatment of Fabry Disease
Fabry disease is caused by a decrease in or loss of the activity of alpha-galactosidase, which causes its substrates globotriaosylceramide (Gb3) and globotriaosylsphingosine (lyso-Gb3) to accumulate in cells throughout the body. This accumulation results in progressive kidney injury due to glomerulo...
Main Authors: | Daisuke Kami, Masashi Yamanami, Takahiro Tsukimura, Hideki Maeda, Tadayasu Togawa, Hitoshi Sakuraba, Satoshi Gojo |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-12-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/0963689720976362 |
Similar Items
-
Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease.
by: Hideaki Sueoka, et al.
Published: (2015-01-01) -
Nano-LC-MS/MS for Quantification of Lyso-Gb3 and Its Analogues Reveals a Useful Biomarker for Fabry Disease.
by: Hideaki Sueoka, et al.
Published: (2015-01-01) -
Comparative urinary globotriaosylceramide analysis by thin-layer chromatography-immunostaining and liquid chromatography-tandem mass spectrometry in patients with Fabry disease
by: Tomoko Shiga, et al.
Published: (2021-12-01) -
Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?
by: Takahiro Tsukimura, et al.
Published: (2021-09-01) -
Anti-drug antibody formation in Japanese Fabry patients following enzyme replacement therapy
by: Takahiro Tsukimura, et al.
Published: (2020-12-01)